Drug Catalog - Product Detail
LIDOCAINE TOPICAL PATCH 5% 30CT
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 00378-9055-93 | MYLAN | 30 | 5% | TRANSDERMAL SYSTEM |
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION Lidocaine patch 5% is comprised of an adhesive material containing 5% lidocaine, USP, which is applied to a pigmented polyethylene/polyester backing film printed with brown ink and covered with a silicone coated polyester film release liner. The release liner is removed prior to application to the skin. The size of the patch is 10 cm × 14 cm. Lidocaine is chemically designated as 2-(Diethylamino)-2’,6’-acetoxylidide, has an octanol: water partition ratio of 43 at pH 7.4, and has the following structure: Each adhesive patch contains 140 mg of lidocaine, USP (50 mg per gram adhesive) in a polyisobutylene adhesive matrix. Lidocaine Structural Formula
How Supplied
HOW SUPPLIED Lidocaine Patch 5% is available containing 140 mg of lidocaine, USP (50 mg per gram adhesive in polyisobutylene adhesive matrix). The rectangular patch consists of a pigmented backing film randomly printed with “Lidocaine Patch 5%” in brown ink, an adhesive matrix layer and a clear removable release liner. They are available as follows: NDC 0378-9055-93 carton containing 30 patches, packaged into individual child-resistant pouches Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] For more information, call Mylan at 1-877-446-3679 (1-877-4-INFO-RX). Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. Revised: 11/2018 LIDO:R4
Indications & Usage
INDICATION AND USAGE Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin .
Dosage and Administration
DOSAGE AND ADMINISTRATION Apply lidocaine patch 5% to intact skin to cover the most painful area. Apply the prescribed number of patches (maximum of 3), only once for up to 12 hours within a 24 hour period. Patches may be cut into smaller sizes with scissors prior to removal of the release liner. (See HANDLING AND DISPOSAL ) Clothing may be worn over the area of application. Smaller areas of treatment are recommended in a debilitated patient, or a patient with impaired elimination. If irritation or a burning sensation occurs during application, remove the patch(es) and do not reapply until the irritation subsides. When lidocaine patch 5% is used concomitantly with other products containing local anesthetic agents, the amount absorbed from all formulations must be considered. Lidocaine patch 5% may not stick if it gets wet. Avoid contact with water, such as bathing, swimming or showering.